Mark A. Goldberg, M.D.
Chief Operating Officer
In his role as Chief Operating Officer (COO), Dr. Goldberg is leading PAREXEL’s global management team to capitalize on the strong market opportunity for global biopharmaceutical services. His focus includes further strengthening client relationships, as well as leveraging PAREXEL’s leadership role in the convergence of services and technology in support of clinical research across all phases of development.
Dr. Goldberg has been an asset to PAREXEL’s executive management team for more than 11 years, leveraging his combined medical, technical, and clinical research expertise. During this time, Dr. Goldberg has held roles of increasing responsibility. He previously served as President of Clinical Research Services and Perceptive Informatics at PAREXEL, and continues to oversee these areas of the Company. Dr. Goldberg has led the strong performance in Clinical Research Services, PAREXEL’s largest business segment. He helped to build Perceptive Informatics into a leading provider of advanced technologies that facilitate the clinical development process, and has overseen the integration of ClinPhone, which PAREXEL recently acquired, making Perceptive one of the industry’s leading eClinical technology providers. Dr. Goldberg has also overseen the geographic expansion of PAREXEL’s clinical development capabilities, most recently including the extension of capabilities in the Asia-Pacific region.
Dr. Goldberg joined PAREXEL in 1997, establishing the Company’s Medical Imaging Group to leverage imaging data as a surrogate end point, or biomarker, in evaluating the safety and efficacy of new products. In 2000, Dr. Goldberg was involved in establishing Perceptive Informatics to deliver advanced technology solutions that improve development and commercialization processes for the biopharmaceutical industry. Today, Perceptive Informatics has a portfolio of products and services including medical imaging, Interactive Voice and Web Response Systems, and the industry-leading IMPACT® Clinical Trial Management System (CTMS), which has approximately 26,000 users — the largest global CTMS user-base.
In 2005, Dr. Goldberg took responsibility for the Clinical Research Services business and has achieved strong performance in new business wins, revenue growth and profitability improvement. During this time, he continued to expand the offerings of the business, which provides capabilities across a broad range of therapeutic areas and all phases of clinical research.
Prior to joining PAREXEL, Dr. Goldberg served as President and Director of WorldCare, Inc., a tele-health spin-off from Massachusetts General Hospital (MGH), which he helped found. Dr. Goldberg holds a degree in Computer Science and Engineering from the Massachusetts Institute of Technology (M.I.T.), and an M.D. degree from the University of Massachusetts Medical School. He completed residency training in Diagnostic Radiology at MGH where he also served as Chief Resident as well as a staff radiologist.